Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry (CONFIDODO)

Sleep Quality During COVID-19 Containment in Children 7 to 12 Years Old, Whether or Not Usually Followed in Child Psychiatry

The purpose of this study is to determine whether sleep disturbances in children aged 7 to 12 during COVID-19 containment are more prevalent in children who received routine psychiatric care before containment compared to children who don't have any psychiatric care.

Study Overview

• Status: Completed
• Conditions: Sleep Disturbance
• Intervention / Treatment: Behavioral: Questionnaires

Detailed Description

The coronavirus epidemic reached France in January 2020 and the WHO declared the COVID-19 outbreak was a pandemic on 11 March 2020. In response to this pandemic the French government announced national containment starting on 17 March 2020. Some recent studies suggest that a containment duration of more than 10 days and an extension beyond the originally announced duration would increase the psychological impact of it.

Sleep is a vital function that contributes to the proper neurophysiological and psychological development of human beings especially children. Sleep disorders can have a major impact on a child's behavior, mood, cognitive performance and metabolism. Sleep disorders are often associated with depression, anxiety and cognitive changes. Chronic sleep disorders are also risk factors for mental illness To our knowledge, no study targeting the quality of sleep in children who usually receive psychiatric care is underway or has been published. It is essential to ask what the quality of sleep in children with a psychiatric diagnosis who suddenly lose their bearings and their usual daily routine (school, therapeutic groups, day hospitals, etc.) after several weeks of containment.

This study is designed to assess different parameters in the 2 groups of children (healthy volunteers and Child with follow-up in child psychiatry) :

• the sleep quality,
• the depression level,
• the anxiety level,
• if socio-demographic factors have an influence on sleep disorders,
• if there is a correlation between children's sleep quality, and anxiety level / sleep quality in their parents.

• Study Type: Observational
• Enrollment (Actual): 247

Contacts and Locations

Study Locations

• France
  • Pontoise, France, 95300
    • Centre Hospitalier René Dubos

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 7 years to 12 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Child aged 7 to 11 years and 11 months included on the first day of containment in France on 17 March 2020 and their parents

Description

Inclusion Criteria:

• Child aged 7 to 11 years and 11 months included on the first day of containment in France on 17 March 2020
• Child receiving care at the CMP of Cergy-le-Haut (medico-psychological center) on the 2020 active patient population (at least one appointment with a child psychiatrist, a psychologist, a psychomotor therapist or a speech therapist or in a therapeutic group between January and March 2020)

OR

• Child not receiving any psychiatric care and having no siblings (half-brother, half-sister) followed in child psychiatry
• No parental opposition

Exclusion Criteria:

• Poor French reading comprehension by parents
• Objection of the child
• Child under guardianship, curatorship or foster care
• Child not on containment : child cared for outside his home everyday (in school and hospital daycare for example).

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Child without follow-up in child psychiatry; Child enrolled, and their parents, must complete online questionnaires	Behavioral: Questionnaires; Child of both groups enrolled, and their parents, must complete online questionnaires
Child with follow-up in child psychiatry; Child enrolled, and their parents, must complete online questionnaires	Behavioral: Questionnaires; Child of both groups enrolled, and their parents, must complete online questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Comparison of sleep quality during COVID-19 containment between children usually followed in child psychiatry and children without follow-up	Sleep quality is assessed in both groups with the Sleep Disturbance Scale for Children (SDSC scale). A score ≥ 45/125 is considered as pathological.	An average of 1 day

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Assessment of child depression in both groups	Child depression is measured using Child Depression Inventory Scale (CDI scale). For each item the score is graded by severity from 0 (normal behavior) to 2 (severe).	An average of 1 day
Assessment of child anxiety in both groups	Child anxiety is measured using Revised Children's Manifest Anxiety Scale (RCMAS). For each item, child answer by Yes or No. The total score is interpreted using the correspondence tables in function of sex and age	An average of 1 day
Assessment of the influence of socio-demographic factors on sleep in both groups	Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). The score obtained is interpreted in function of socio-demographic factors (age, sex, lifestyle, couple status, profession and socio-professional category, education)	An average of 1 day
Measure of the correlation between child sleep quality and parents sleep quality (anxiety level) in both groups	Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). For their parents, sleep quality and anxiety level are measured with a numerical scale between 0 and 10. For sleep quality, 0 correspond to a very poor quality and 10 to a very good quality. For anxiety level, 0 correspond to no anxiety and 10 to a severe anxiety. The score obtained for child is interpreted in function of their parents score.	An average of 1 day
Assessment of sleep disturbance based on psychiatry diagnoses in the group of children usually followed in child psychiatry	Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)	An average of 1 day
Assessment of child anxiety based on psychiatry diagnoses in the group of children usually followed in child psychiatry	Child anxiety is measured using Revised Children's Manifest Anxiety Scale (RCMAS). For each item, child answer by Yes or No. The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)	An average of 1 day
Assessment of child depression based on psychiatry diagnoses in the group of children usually followed in child psychiatry	Child depression is measured using Child Depression Inventory Scale (CDI scale). For each item the score is graded by severity from 0 (normal behavior) to 2 (severe). The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)	An average of 1 day

Collaborators and Investigators

• Sponsor: Centre Hospitalier René Dubos
• Investigators: Principal Investigator: Erwan VION, Centre Hospitalier René Dubos

Study record dates

Study Major Dates

• Study Start (Actual): May 4, 2020
• Primary Completion (Actual): June 4, 2020
• Study Completion (Actual): June 4, 2020

Study Registration Dates

• First Submitted: April 29, 2020
• First Submitted That Met QC Criteria: April 29, 2020
• First Posted (Actual): April 30, 2020

Study Record Updates

• Last Update Posted (Actual): July 2, 2020
• Last Update Submitted That Met QC Criteria: July 1, 2020
• Last Verified: April 1, 2020

More Information

Terms related to this study

• Keywords: Mental Health; Anxiety; Children; COVID-19; Psychological Distress; Containment; Child Psychiatry; Sleep Wake Disorders; Sleep Disturbance scale for children
• Additional Relevant MeSH Terms: Mental Disorders; Nervous System Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Sleep Wake Disorders; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19; Dyssomnias; Parasomnias
• Other Study ID Numbers: CHRD 0520

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No